Shahbazi Massoumeh, Ahmadinejad Minoo, Fakhrzadegan Shahnaz
Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
Department of Hematology and Oncology, School of Medicine, Iran University of Medical Science, Tehran, Iran.
Iran J Pathol. 2021 Summer;16(3):332-336. doi: 10.30699/IJP.2020.131638.2463. Epub 2021 May 9.
Hereditary deficiency of plasma prekallikrein (PPK) is a rare autosomal recessive disease. The affected patients are often asymptomatic and diagnosed incidentally during preoperative investigations or during hospitalization by isolated prolongation of activated partial thromboplastin time (aPTT). In this article, we report, a 46-year-old woman who was candidate for two invasive procedures (thyroid FNA and hysterectomy) and underwent preoperative evaluation. Due to prolonged aPTT with normal PT she was referred to the IBTO reference coagulation laboratory for specific coagulation assays. Ultimately, the examinations revealed severe PPK deficiency (<1%) with partial deficiency of factor XII level (25%).
血浆前激肽释放酶(PPK)遗传性缺乏是一种罕见的常染色体隐性疾病。受影响的患者通常无症状,在术前检查或住院期间因活化部分凝血活酶时间(aPTT)单独延长而偶然被诊断出来。在本文中,我们报告了一名46岁女性,她是两项侵入性手术(甲状腺细针穿刺活检和子宫切除术)的候选者,并接受了术前评估。由于aPTT延长而PT正常,她被转介到IBTO参考凝血实验室进行特定的凝血检测。最终,检查发现严重的PPK缺乏(<1%)以及因子XII水平部分缺乏(25%)。